No Data
Express News | National Medical Products Administration: Deploys pilot work on segmented production reform of biological products.
Who's buying? The A-share market is closed, but the Hong Kong stock market is still going strong! There's a big shift in foreign capital underway.
According to the latest report published by Goldman Sachs, after the People's Bank of China announced easing measures and the September Political Bureau meeting, mainland consumer stocks rebounded strongly by an average of about 32% in the past week.
Express News | Hong Kong stock CRO concept stocks soared at the close, what happened?
Biosino Bio-Tec (08247) plans to appoint RSM Hong Kong as the auditor.
biosino bio-tec (08247) announced that due to the company's inability to reach an agreement with Ernst & Young by December 2024...
Biosino Bio-Tec (08247.HK): The loss attributable to the parent company in the first half of the year was 13.182 million yuan.
Biosino Bio-technology (08247.HK) announced on August 29th that as of June 30th, 2024, the company achieved revenue of RMB 0.134 billion, a decrease of 3.8% compared to the same period last year; gross profit was RMB 58.531 million, a decrease of 12.2% compared to the same period last year; the company's net loss attributable to shareholders was RMB 13.182 million, compared to RMB 5.423 million in the same period last year; basic loss per share was RMB 0.091.
BIOSINO BIO-TEC: Interim Report 2024
No Data
No Data